Mark Jit
112 posts

Mark Jit
@markjit
Modeller, epidemiologist, economist at @LSHTM, visiting prof at @HKUniversity, previously at Public Health England. Interested in vaccines, infectious diseases.










Our recently published global impact and cost-effectiveness employed comparative modelling to evaluate outcomes of 1-dose vs 2-dose HPV vaccination schedules @BMCMedicine doi.org/10.1186/s12916… ✨@EmilyAnnika @jflaprise @hadley_liza @AllisonPortnoy @markjit @cmmid_lshtm +++✨



In 2020 cervical cancer killed 342,000 women 🌍 95% of cervical #cancer cases are caused by #HPV @TheEconomist uses model by Kaja Abbas & @markjit to estimate successful global HPV #vaccine initiative could reduce cervical cancer deaths by 2.65m by 2030💉📉👇

Congratulations to LSHTM’s @markjit for being elected a Fellow of @acmedsci 🎉 Mark joins 59 influential scientists from UK institutions awarded the prestigious fellowship this year, for helping advance biomedical & health science.🔬#AMSFellows2023 👉bit.ly/43bIRHP


Underlining the collections' findings on RSV burden @PSrikantiah and @findingpneumo discuss the data included in the collection and the scale of RSV burden. @gatesfoundation bmcmedicine.biomedcentral.com/articles/10.11…




Simon R Procter and colleagues explore the global health impact and cost-effectiveness of maternal immunisation against Group B Streptococcus. doi.org/10.1371/journa… @mert0248 @markjit @joylawn @LSHTM_GHECO @MARCH_LSHTM

🔦Spotlight on the @cmmid_lshtm @gatesfoundation grant to support “Women in Modelling at LSHTM” 💪Giving us a deeper understanding of the barriers for women in infectious disease mathematical modelling so that we can work to address them. 👇 bit.ly/3ylBW1b #IWD2023

Modelling collaboration from @markjit @LSHTM @rozeggo @cmmid_lshtm @just_nonvignon @AfricaCDC @AnnaVassall @cap1024 et al. Assessing the impacts of COVID-19 vaccination programmes in 27 African countries: bmcmedicine.biomedcentral.com/articles/10.11…



